Resources
Peer-Reviewed Articles (open access)
- 2021 AHA/ACC Guideline for the Evaluation of Chest Pain
- 2014 AHA/ACC Guideline for the Management of Patients
With Non–ST-Elevation Acute Coronary Syndromes - Recommendations for Institutions
Transitioning to High-Sensitivity
Troponin Testing - Fourth Universal Definition of Myocardial Infarction (2018)
Videos
- Evidence Based Medicine and the Use of High Sensitivity Troponin
- High Sensitivity Troponin General Education
- High-Sensitivity Troponin in Clinical Practice: From Evidence to Implementation
Requires account and log in access via MedScape - The Value of High-Sensitivity Troponin: Optimizing Outcomes & Operations in the Emergency Department
Requires account and log in access via MedScape
Conversion to High-Sensitivity Cardiac Troponin Test
As part of an enterprise wide implementation of Roche Diagnostics clinical chemistry and immunoassay test platforms, TriCore will be converting to a high-sensitivity cardiac troponin T test to improve the management of chest pain patients with suspected acute coronary syndromes.
This web page contains important information and educational resources regarding the conversion from a contemporary cardiac troponin test to a high sensitivity cardiac troponin test and will be updated as new details and resources become available.
Questions regarding this conversion can be directed to:
Dr. Melissa Budelier
Laboratory Director, Clinical Chemistry & Toxicology
505.938.8460